Invesco’s TuHURA Biosciences HURA Stock Holding History

Invesco’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,159	Closed	-$27.1K	–	3959
2026 Q1	$27.1K	Buy	15,159 +1,386	+10%	+$1.7K	﹤0.01%	3721
2025 Q4	$10.4K	Buy	13,773 +272	+2%	+$521	﹤0.01%	3743
2025 Q3	$33.5K	Hold	13,501	–	–	﹤0.01%	3762
2025 Q2	$30.1K	Buy	+13,501	New	+$45.6K	﹤0.01%	3749

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Invesco's HURA Position: Q2 2026 in Review

Invesco sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 15,159 shares — an estimated $27.1K sold.

Invesco first reported a position in HURA in Q2 2025 and held it in 4 quarters. The position peaked at $33.5K in Q3 2025. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Invesco reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
Invesco sold 15,159 TuHURA Biosciences shares in Q2 2026, an estimated $27.1K.
Invesco first reported a position in TuHURA Biosciences in Q2 2025 and held it in 4 quarters.
Invesco's TuHURA Biosciences position peaked at $33.5K in Q3 2025.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.